We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.49B
1-Year Est. Return 208.7%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
+208.7%
3 Year Est. Return
+777.5%
5 Year Est. Return
+1,114.43%
10 Year Est. Return
+23,630.52%
AUM
$866M
AUM Growth
+$41.2M
Cap. Flow
-$23.2M
Cap. Flow %
-2.68%
Top 10 Hldgs %
41.18%
Holding
70
New
22
Increased
15
Reduced
16
Closed
15

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$33.3M
2
MCK icon
McKesson
MCK
+$31.1M
3
ADVM
Adverum Biotechnologies
ADVM
+$20.8M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$18.6M
5
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$18.1M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$37.6M
2
AGN
Allergan Inc
AGN
+$28.8M
3
ZBH icon
Zimmer Biomet
ZBH
+$26.6M
4
UHS icon
Universal Health Services
UHS
+$26.1M
5
A icon
Agilent Technologies
A
+$19.9M

Sector Composition

Rank Sector Weight
1 Healthcare 75.81%
2 Miscellaneous 18.86%
3 Technology 2.52%
4 Communication Services 1.66%
5 Industrials 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OEF icon
1
PUT
iShares S&P 100 ETF
OEF
$20.5B
$49.2M 5.68%
+450,000
New +$39.6M
BHC icon
2
Bausch Health
BHC
$2.36B
$43.6M 5.04%
332,567
+104,737
+46% +$12.5M
AGN
3
DELISTED
Allergan plc
AGN
$39.5M 4.57%
163,898
-12,800
-7% -$2.86M
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
$35.6M 4.11%
784,459
+60,643
+8% +$2.53M
CELG
5
DELISTED
Celgene Corp
CELG
$35M 4.04%
+369,400
New +$33.3M
FOLD
6
DELISTED
Amicus Therapeutics
FOLD
$34M 3.92%
5,706,906
-1,943,362
-25% -$10.2M
MCK icon
7
McKesson
MCK
$104B
$31.5M 3.64%
+161,765
New +$31.1M
CMRX
8
DELISTED
Chimerix, Inc.
CMRX
$31M 3.58%
1,121,032
-216,118
-16% -$5.25M
ARRY
9
DELISTED
Array Biopharma Inc
ARRY
$29.8M 3.44%
8,342,045
+256,100
+3% +$1.01M
RCPT
10
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$27.3M 3.16%
439,878
-313,782
-42% -$15M
TRIV
11
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$25.5M 2.95%
1,751,518
+210,870
+14% +$3.06M
RAD
12
DELISTED
Rite Aid Corporation
RAD
$25.5M 2.94%
263,036
+139,343
+113% +$18M
HCA icon
13
HCA Healthcare
HCA
$90.5B
$23.2M 2.67%
328,292
-286,767
-47% -$19M
CSLT
14
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$21.8M 2.52%
1,683,817
+519,560
+45% +$6.85M
ADVM
15
DELISTED
Adverum Biotechnologies
ADVM
$21.5M 2.49%
+69,946
New +$20.8M
MNK
16
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$20.9M 2.41%
+231,389
New +$18.1M
GMED icon
17
Globus Medical
GMED
$11.1B
$19M 2.2%
966,300
+133,312
+16% +$2.74M
CBST
18
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$18.8M 2.17%
+283,756
New +$18.6M
ZSPH
19
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$18.6M 2.15%
+474,132
New +$15.7M
NUVA
20
DELISTED
NuVasive, Inc.
NUVA
$17.4M 2.01%
498,441
-3,850
-0.8% -$137K
TVTY
21
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$16.4M 1.9%
1,026,503
-208,268
-17% -$3.53M
OXFD
22
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$16.3M 1.88%
1,066,415
+105,595
+11% +$1.62M
NSTG
23
DELISTED
NanoString Technologies, Inc.
NSTG
$15.9M 1.84%
1,453,655
+319,707
+28% +$3.95M
HNT
24
DELISTED
HEALTH NET INC
HNT
$15.4M 1.78%
+334,935
New +$14.9M
MODN
25
DELISTED
MODEL N, INC.
MODN
$14.4M 1.66%
1,457,278
+96,400
+7% +$931K
1
2 3

Similar funds

FCM
Fairholme Capital Management South Miami, Florida $1.49B AUM 28.35% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return

Redmile Group's Q3 2014 Portfolio in Review

As of Q3 2014, Redmile Group held 70 positions worth $866M, up 5% from $825M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Redmile Group's Q3 2014 filing shows 22 new, 15 increased, 16 reduced and 15 closed positions. Its largest new stake was Celgene Corp: 369,400 shares worth $35M. The largest sale was Medtronic, an estimated $37.6M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 83% a quarter earlier, followed by Miscellaneous and Technology.

  • Redmile Group's largest Q3 2014 buy was Celgene Corp: 369,400 shares worth $35M.
  • Redmile Group added most to Rite Aid Corporation in Q3 2014, an estimated $18M increase.
  • Redmile Group's biggest Q3 2014 reduction was Universal Health Services, cutting an estimated $26.1M.
  • Redmile Group fully exited Medtronic in Q3 2014, selling an estimated $37.6M.
  • Redmile Group's ten largest holdings make up 41% of its $866M portfolio in Q3 2014.
  • Redmile Group opened 22 new positions and closed 15 in Q3 2014.
  • Redmile Group's portfolio value rose 5% quarter-over-quarter to $866M.

Based on Redmile Group's 13F filing for Q3 2014, filed 14 Nov 2014.